Malignant tumors pose a major threat to survival largely because they shed mobile cells that can form secondary tumors in other tissues.
Potential new therapeutic target identified for controlling high blood sugar
3/22/2014
A UT Southwestern Medical Center study has identified a new potential therapeutic target for controlling high blood sugar, a finding that could help the estimated 25 million Americans with type 2 diabetes.Researchers showed that lipid molecules called phosphatidic acids enhance glucose production in the liver.
Managing menopausal symptoms: internists must play a larger role
3/22/2014
The number of menopausal women is projected to reach 50 million by 2020. With changing views on appropriate therapies to control symptoms and new treatments available and on the horizon, most internists lack the core competencies and experience to meet the needs of women entering menopause, according to a provocative Commentary published in Journal of Women's Health, a peer-reviewed publication...
Researchers create smartphone device that performs blood tests
3/22/2014
Researchers have created a smartphone device that can perform blood tests - a creation they say could "improve the quality of life" for people undergoing treatment for the prevention of blood clots.The formation of blood clots in the arteries and veins can increase the risk of heart attack and stroke.
A study of over 50,000 women participating in the UK NHS Breast Screening Programme has found that, while three-yearly screening intervals are appropriate for the majority of women, approximately one third of women are at higher risk of developing cancer and might benefit from more frequent mammograms.
Analysis of data from the UK NHS Breast Screening Programme has shown significant variations in the outcomes of treatment for women with ductal carcinoma in situ (DCIS) between UK hospitals.
New study shows endochoice fuse system detects significantly more pre-cancerous polyps
3/21/2014
EndoChoice® has announced that positive results of a pivotal comparison study of standard forward-viewing colonoscopy (SFV) and EndoChoice's Full Spectrum Endoscopy™ System (Fuse™) were published in The Lancet Oncology. The study determined that standard forward-viewing colonoscopes missed 41% of adenomas (pre-cancerous polyps).
New drug raises potential for cancer treatment revolution
3/21/2014
A revolution in cancer treatment could soon be underway following a breakthrough that may lead to a dramatic improvement in cancer survival rates.
Inflammation mobilizes tumor cells
3/21/2014
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have discovered a novel feedback mechanism that provides a mechanistic link between chronic inflammation and carcinogenesis.Malignant tumors pose a major threat to survival largely because they shed mobile cells that can form secondary tumors in other tissues.
Differences seen in HPV positive, negative in squamous cell head, neck cancer
3/21/2014
Neck mass and sore throat appear to be the initial symptoms in patients with oropharyngeal (mouth and throat) squamous cell carcinoma (OPSCC), and the symptoms appear to be associated with the human papillomavirus (HPV) status of the tumors. The incidence of OPSCC has been on the rise, unlike other head and neck cancers that have been on the decline.